The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing ...
De mede-auteur van de studie vertelde aan Newsweek dat deze aanpak zou kunnen helpen bij het aanpakken van uitdagingen die ...
“Solid tumors are very diverse,” Zhu said. “Some tumor cells lose or hide the antigen a therapy is designed to find — what we ...
The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing ...
Immunotherapy has revolutionized cancer care by training the immune system to detect and destroy tumors. For many patients, it works very well in shrinking tumors and sending cancer into remission, an ...
UCLA's AlloESO-T cell therapy targets solid tumors at an estimated $5,000 per dose — a fraction of current costs — but remains in preclinical mouse trials only.
UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through ...
T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down ...
A woman undergoing cancer treatment will attend a Parkrun to encourage more stem cell donors.
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results